Latest news
CMPS Stock Climbs After-Hours: Analyst Sees Depression Drug Approval By H1 2027 Or Sooner After Strong Trial Data - StocktwitsStocktwits · Sat, 08 Aug 2026 16:47:06 GMTAnalyst Sees Larimar as Undervalued on Nomlabofusp’s Strong Efficacy and On‑Track BLA, Reiterates Buy Rating Ahead of 2027 FA Launch - TipRanksTipRanks · Wed, 05 Aug 2026 11:41:13 GMT